EICHOR
● Active Not Recruiting
Nipocalimab in Moderate to Severe Sjogren's Disease
Condition: Sjogrens Syndrome · Sponsor: Janssen Research & Development, LLC
About this study
The purpose of this study is to evaluate the clinical efficacy and safety of nipocalimab in participants with moderate to severe Sjogren's disease (SjD).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (254)
| Advanced Clinical Research Center | Chula Vista, California, United States | — |
| Providence Medical Foundation | Fullerton, California, United States | — |
| Arthritis & Osteoporosis Medical Center - La Palma | La Palma, California, United States | — |
| NovaMed Research | Monterey Park, California, United States | — |
| Medvin Clinical Research San Leandro | San Leandro, California, United States | — |
| Providence Saint John s Health Center | Santa Monica, California, United States | — |
| Solace Clinical Research California | Tustin, California, United States | — |
| Inland Rheumatology Clinical Trials Inc. | Upland, California, United States | — |
| Denver Arthritis Clinic | Denver, Colorado, United States | — |
| Clinical Research of West Florida Inc | Clearwater, Florida, United States | — |
| UF Health Rheumatology | Jacksonville, Florida, United States | — |
| Suncoast Clinical Research | New Port Richey, Florida, United States | — |
+ 242 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.